1-Methylpiperazine → HCID 44611001, compound

HRID 1916085Notes

Reaction equation

HRID 1916085 reaction equation
Br[C:2]1[CH:7]=[CH:6][C:5]([C@@H:8]([NH:10][C:11]2[N:12]=[CH:13][C:14]3[N:20]([CH3:21])[C:19](=[O:22])[C:18]([CH3:24])([CH3:23])[CH2:17][N:16]([CH:25]4[CH2:29][CH2:28][CH2:27][CH2:26]4)[C:15]=3[N:30]=2)[CH3:9])=[CH:4][CH:3]=1.[CH3:31][N:32]1[CH2:37][CH2:36][NH:35][CH2:34][CH2:33]1.C(P(C(C)(C)C)C1C=CC=CC=1C1C=CC=CC=1)(C)(C)C.[O-]P([O-])([O-])=O.[K+].[K+].[K+]>C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd].COCCOC>[CH:25]1([N:16]2[CH2:17][C:18]([CH3:24])([CH3:23])[C:19](=[O:22])[N:20]([CH3:21])[C:14]3[CH:13]=[N:12][C:11]([NH:10][C@H:8]([C:5]4[CH:6]=[CH:7][C:2]([N:35]5[CH2:36][CH2:37][N:32]([CH3:31])[CH2:33][CH2:34]5)=[CH:3][CH:4]=4)[CH3:9])=[N:30][C:15]2=3)[CH2:29][CH2:28][CH2:27][CH2:26]1

Participants

7

Conditions

Temperature
100 °C

Procedure

(S)-2-(1-(4-Bromophenyl)ethylamino)-9-cyclopentyl-5,7,7-trimethyl-8,9-dihydro-5H-pyrimido[4,5-b][1,4]diazepin-6(7H)-one (100 mg, 0.2117 mmol), 1-methylpiperazine (84.82 mg, 93.93 μL, 0.8468 mmol), di-tert-butyl-(2-phenylphenyl)phosphane (6.317 mg, 0.02117 mmol) and K3PO4 (89.87 mg, 0.4234 mmol) were taken in up DME (2 mL) and degassed using cycles of vacuum and nitrogen. Pd2DBA3 (19.39 mg, 0.02117 mmol) was added and the reaction mixture was further degassed and then heated at 100° C. in a sealed tube for 4 hours and then allowed to cool to the ambient temperature. The reaction mixture was then diluted with ethyl acetate (5 mL) and filtered. The filtrate was concentrated in vacuo and the residue purified by mass directed HPLC and the combined product fractions passed through a bicarbonate cartridge and lypholized to give the title compound as a white solid (9.9 mg, 10% yield).

Workup

  1. customdegassed
  2. customthe reaction mixture was further degassed
  3. temperatureto cool to the ambient temperature
  4. additionThe reaction mixture was then diluted with ethyl acetate (5 mL)
  5. filtrationfiltered
  6. concentrationThe filtrate was concentrated in vacuo
  7. customthe residue purified by mass

Sources & evidence

ORD record
ord-8f3625422a024dd486beaf2215e15082
Source dataset
uspto-grants-2013_12
Patent number
US08618106B2

Reaction notes

Loading…